suggested by:
risk factors for lung cancer eg. older patient, past or current smoker, industrial exposures, etc
larger size
spiculated margins or lobulated contour
enhancement characteristics with IV contrast
pleural retraction (visceral pleura pulled towards the nodule)
growth rate:
if cavitating, then maximal wall thickness > 16mm (90% are malignant - usually squamous cell lung cancer as small cell lung cancer rarely cavitates)
mediastinal lynphadenopathy
extensive lymphadenopathy is seens with small cell carcinoma lung, lymphoma, leukaemia, and metastases from renal cell Ca, melanoma and testicular cancer
bronchogenic carcinomas most commonly are seen in upper lobes esp. anterior segment with a R:L ratio of 3:2
squamous cell lung cancers generally present as a central mass +/- atelectasis / post-obstructive pneumonia, while 30% cavitate
adenocarcinoma tends to present as a peripheral nodule or mass, and should be considered in apparent pneumonic changes which fail to resolve
small cell carcinoma usually present as a central mass (80% cases) with extensive mediastinal lymphadenopathy
large cell carcinoma tends to present as a large peripheral mass
NB. a new solitary pulmonary nodule in a patient with an extra-thoracic primary neoplasm usually represents a new primary lung cancer unless the primary is a melanoma or sarcoma in which case a solitary metastasis is more likely
NB. synchronous multiple lung cancers are uncommon in < 5%
but tend to be a feature of rare primary lung neoplasms that originate from epithelial (pneumocytes and neuroendocrine), mesenchymal (vascular and meningothelial) and lymphoid tissues of the lung
1)
10-15% of patients treated for lung cancer develop a new lung cancer with average time interval of ~5 years
metastatic tumours to the lung are generally spread via pulmonary arteries and thus tend to occur in lower zones of the lungs, and tend to be peripheral (90% are in outer 1/3rd)